Group One Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,475,200
Closed -$43.7M 8258
2023
Q4
$43.7M Buy
1,475,200
+1,269,300
+616% +$25.3M 0.12% 116
2023
Q3
$3.27M Sell
205,900
-159,900
-44% -$2.66M 0.01% 1245
2023
Q2
$6.9M Sell
365,800
-217,300
-37% -$2.57M 0.02% 740
2023
Q1
$2.24M Buy
583,100
+486,200
+502% +$2.07M 0.01% 1433
2022
Q4
$481K Sell
96,900
-24,600
-20% -$133K ﹤0.01% 3080
2022
Q3
$581K Buy
121,500
+33,900
+39% +$179K ﹤0.01% 3095
2022
Q2
$394K Sell
87,600
-25,600
-23% -$111K ﹤0.01% 3649
2022
Q1
$539K Sell
113,200
-83,900
-43% -$465K ﹤0.01% 3728
2021
Q4
$1.46M Buy
197,100
+101,000
+105% +$628K ﹤0.01% 2945
2021
Q3
$545K Sell
96,100
-139,600
-59% -$807K ﹤0.01% 4098
2021
Q2
$1.55M Buy
235,700
+73,000
+45% +$509K ﹤0.01% 2906
2021
Q1
$1.32M Buy
162,700
+112,600
+225% +$919K ﹤0.01% 2917
2020
Q4
$323K Buy
50,100
+36,900
+280% +$215K ﹤0.01% 3673
2020
Q3
$48K Sell
13,200
-28,900
-69% -$117K ﹤0.01% 4681
2020
Q2
$194K Sell
42,100
-6,700
-14% -$28.5K ﹤0.01% 3404
2020
Q1
$166K Sell
48,800
-260,100
-84% -$1.14M ﹤0.01% 2900
2019
Q4
$1.58M Sell
308,900
-58,500
-16% -$199K 0.01% 1484
2019
Q3
$889K Buy
367,400
+318,500
+651% +$846K 0.01% 1833
2019
Q2
$106K Sell
48,900
-22,500
-32% -$53.2K ﹤0.01% 3307
2019
Q1
$193K Buy
71,400
+500
+0.7% +$2.17K ﹤0.01% 2736
2018
Q4
$340K Buy
70,900
+43,400
+158% +$263K ﹤0.01% 2269
2018
Q3
$260K Sell
27,500
-79,400
-74% -$763K ﹤0.01% 2820
2018
Q2
$1.04M Sell
106,900
-111,700
-51% -$1.18M 0.01% 1691
2018
Q1
$2.3M Buy
218,600
+164,500
+304% +$1.62M 0.02% 916
2017
Q4
$347K Sell
54,100
-36,900
-41% -$228K ﹤0.01% 2547
2017
Q3
$696K Buy
91,000
+53,600
+143% +$356K 0.01% 1822
2017
Q2
$266K Sell
37,400
-1,400
-4% -$6.41K ﹤0.01% 2438
2017
Q1
$150K Sell
38,800
-127,600
-77% -$372K ﹤0.01% 2721
2016
Q4
$339K Buy
166,400
+104,200
+168% +$209K ﹤0.01% 2041
2016
Q3
$167K Buy
62,200
+61,700
+12,340% +$179K ﹤0.01% 2603
2016
Q2
$2K Sell
500
-14,300
-97% -$89.7K ﹤0.01% 4451
2016
Q1
$126K Buy
14,800
+3,100
+26% +$26.2K ﹤0.01% 2668
2015
Q4
$159K Sell
11,700
-16,700
-59% -$206K ﹤0.01% 2667
2015
Q3
$273K Sell
28,400
-35,200
-55% -$515K ﹤0.01% 2268
2015
Q2
$915K Buy
63,600
+23,600
+59% +$259K 0.01% 1279
2015
Q1
$358K Buy
40,000
+200
+0.5% +$1.45K 0.01% 1884
2014
Q4
$243K Buy
39,800
+18,500
+87% +$169K ﹤0.01% 2142
2014
Q3
$226K Buy
21,300
+12,000
+129% +$136K ﹤0.01% 2285
2014
Q2
$110K Sell
9,300
-5,100
-35% -$64K ﹤0.01% 2892
2014
Q1
$215K Sell
14,400
-21,600
-60% -$341K ﹤0.01% 2383
2013
Q4
$528K Buy
36,000
+21,000
+140% +$323K 0.01% 1623
2013
Q3
$255K Sell
15,000
-8,800
-37% -$155K ﹤0.01% 2169
2013
Q2
$395K Buy
+23,800
New +$386K 0.01% 1543

Other funds holding IMGN

Group One Trading's IMGN Position: Q4 2023 in Review

Group One Trading sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 238,327 shares — an estimated $4.75M sold.

Group One Trading first reported a position in IMGN in Q2 2013 and held it in 33 quarters. The position peaked at $3.78M in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Group One Trading reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 238,327 Immunogen Inc shares in Q4 2023, an estimated $4.75M.
  • Group One Trading first reported a position in Immunogen Inc in Q2 2013 and held it in 33 quarters.
  • Group One Trading's Immunogen Inc position peaked at $3.78M in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.